Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases

A catalogue of splice junction sequences

Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,742

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498

Mechanisms of Alternative Pre-Messenger RNA Splicing

Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142

Messenger-RNA-binding proteins and the messages they carry

Dreyfuss, G., Kim, V. N., & Kataoka, N. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm760 · Cited by 1,457

Pre-mRNA splicing and human diseasePreprint

Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,248

Alternative splicing: increasing diversity in the proteomic world

Graveley, B. R. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(00)02176-4 · Cited by 1,228

Exon Recognition in Vertebrate Splicing

Berget, S. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2411 · Cited by 1,090

Sorting out the complexity of SR protein functions

Graveley, B. R. (2000) · RNA · doi:10.1017/s1355838200000960 · Cited by 1,080

RBM4 Interacts with an Intronic Element and Stimulates Tau Exon 10 Inclusion

Kar, A. N., Havlioglu, N., Tarn, W., & Wu, J. Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603971200 · Cited by 59

Up-regulation of the ubiquitous alternative splicing factor Tra2β causes inclusion of a germ cell-specific exon

Venables, J. P., Bourgeois, C. F., Dalgliesh, C., Kister, L., Stévenin, J., & Elliott, D. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi233 · Cited by 57

Roles of Cholesterol and Lipids in the Etiopathogenesis ofAlzheimer′s Disease

Rojo, L. E., Sjöberg-Herrera, M. K., Hernández, P., Zambrano, C. A., & Maccioni, R. B. (2006) · BioMed Research International · doi:10.1155/jbb/2006/73976 · Cited by 57

SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations

Gao, L., Wang, J., Wang, Y., & Andreadis, A. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.10.004 · Cited by 59

Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation

Schirer, Y., Malishkevich, A., Ophir, Y., Lewis, J. M., Giladi, E., & Gozes, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087383 · Cited by 57

Disulfide Bonding in Neurodegenerative Misfolding Diseases

Mossuto, M. F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/318319 · Cited by 56

Independent tubulin binding and polymerization by the proline-rich region of Tau is regulated by Tau's N-terminal domain

McKibben, K. M., & Rhoades, E. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010172 · Cited by 55

Tau Aggregation

Hernández, F., Ferrer, I., Pérez, M., Zabala, J. C., del Rı́o, J. A., & Ávila, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.024 · Cited by 49

Mass spectrometry‐based targeted proteomics for analysis of protein mutations

Lin, T., Zhang, T., Kitata, R. B., Liu, T., Smith, R. D., Qian, W., & Shi, T. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21741 · Cited by 51

Investigating the utility of human embryonic stem cell‐derived neurons to model ageing and neurodegenerative disease using whole‐genome gene expression and splicing analysis

Patani, R., Lewis, P. A., Trabzuni, D., Puddifoot, C. A., Wyllie, D. J. A., WALKER, R. E., Smith, C., Hardingham, G. E., Weale, M. E., Hardy, J., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07825.x · Cited by 52

Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation

Tambini, M. D., Norris, K. A., & D'adamio, L. (2020) · eLife · doi:10.7554/elife.52612 · Cited by 47

The Effect of a ΔK280 Mutation on the Unfolded State of a Microtubule-Binding Repeat in Tau

Huang, A., & Stultz, C. M. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000155 · Cited by 52

Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer

Papin, S., & Paganetti, P. (2020) · Brain Sciences · doi:10.3390/brainsci10110862 · Cited by 45

Intermediate filament-associated cytolinker plectin 1c destabilizes microtubules in keratinocytes

Valencia, R. G., Walko, G., Janda, Ľ., Nováček, J., Mihailovska, E., Reipert, S., Andrä, K., & Wiche, G. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-06-0488 · Cited by 48

Neurodegeneration and sport

Davis, G. A., Castellani, R. J., & McCrory, P. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000722 · Cited by 47

PSF Suppresses Tau Exon 10 Inclusion by Interacting with a Stem-Loop Structure Downstream of Exon 10

Ray, P., Kar, A. N., Fushimi, K., Havlioglu, N., Chen, X., & Wu, J. Y. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9634-z · Cited by 51

Neuronal nuclear tau and neurodegeneration

Antón‐Fernández, A., Vallés‐Saiz, L., Ávila, J., & Hernández, F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.015 · Cited by 45

FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics

LeBoeuf, A. C., Levy, S. F., Gaylord, M. A., Bhattacharya, A., Singh, A. K., Jordan, M. A., Wilson, L., & Feinstein, S. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803519200 · Cited by 46

Alternative promoter usage generates novel shorter MAPT mRNA transcripts in Alzheimer’s disease and progressive supranuclear palsy brains

Huin, V., Buée, L., Behal, H., Labreuche, J., Sablonnière, B., & Dhaenens, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-12955-7 · Cited by 43

Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy

Lionnet, A., Wade, M. A., Corbillé, A.-G., Prigent, A., Paillusson, S., Tasselli, M., Gonzales, J. A., Durieu, E., Rolli‐Derkinderen, M., Coron, E., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0568-3 · Cited by 45

An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5′ splice site of tau exon 10, whose misregulation causes frontotemporal dementia

Wang, Y., Wang, J., Gao, L., Stamm, S., & Andreadis, A. (2011) · Gene · doi:10.1016/j.gene.2011.06.020 · Cited by 43

RNA editing of microtubule-associated protein tau circular RNAs promotes their translation and tau tangle formation

Welden, J. R., Margvelani, G., Maquera, K. A. A., Gudlavalleti, B., Sardón, S. C. M., Campos, A. R., Robil, N., Lee, D. C., Hernandez, A. G., Wang, W., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1129 · Cited by 43

A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer’s disease

García‐Escudero, V., Ruiz-Gabarre, D., Gargini, R., Pérez, M., García, E., Cuadros, R., Hernández, I. H., Cabrera, J. R., García‐Escudero, R., Lucas, J. J., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02317-z · Cited by 42

Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases

Diez, L., & Wegmann, S. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01056 · Cited by 40

Invited review: Drug development for tauopathies

Grüninger, F. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12192 · Cited by 40

The Role of Tau Proteoforms in Health and Disease

Waheed, Z., Choudhary, J., Jatala, F. H., Fatimah, Noor, A., Zerr, I., & Zafar, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03387-8 · Cited by 41

Growth hormone action in the developing neural retina: A proteomic analysis

Baudet, M., Hassanali, Z., Sawicki, G., List, E. O., Kopchick, J. J., & Harvey, S. (2008) · PROTEOMICS · doi:10.1002/pmic.200700952 · Cited by 39

Aluminum and Tau in Neurofibrillary Tangles in Familial Alzheimer’s Disease

Mold, M. J., O’Farrell, A., Morris, B., & Exley, C. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210011 · Cited by 42

T he MAPT gene is differentially methylated in the progressive supranuclear palsy brain

Huin, V., Deramecourt, V., Caparros-Lefebvre, D., Maurage, C., Duyckaerts, C. J., Kövari, E., Pasquier, F., Buée‐Scherrer, V., Labreuche, J., Behal, H., et al. (2016) · Movement Disorders · doi:10.1002/mds.26820 · Cited by 38

The human MAPT locus generates circular RNAs

Welden, J. R., van Doorn, J., Nelson, P. T., & Stamm, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.023 · Cited by 37

Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1–42 in CSF for the Diagnosis of Alzheimer’s Disease

Pottiez, G., Yang, L., Stewart, T., Song, N., Aro, P., Galasko, D. R., Quinn, J. F., Peskind, E. R., Shi, M., & Zhang, J. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00829 · Cited by 37

What’s in a Gene? The Outstanding Diversity of MAPT

Ruiz-Gabarre, D., Carnero-Espejo, A., Ávila, J., & García‐Escudero, V. (2022) · Cells · doi:10.3390/cells11050840 · Cited by 39

RNA Protein Granules Modulate tau Isoform Expression and Induce Neuronal Sprouting

Moschner, K., Sündermann, F., Meyer, H., da Graça, A. P., Appel, N., Paululat, A., Bakota, L., & Brandt, R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541425 · Cited by 38

Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease

Nanjundaiah, S., Chidambaram, H., Chandrashekar, M., & Chinnathambi, S. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00883-6 · Cited by 36

Cryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research

Todd, T. W., Islam, N. N., Cook, C. N., Caulfield, T. R., & Petrucelli, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.012 · Cited by 37

Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies

Wang, Z.-H., Liu, P., Liu, X., Yu, S. P., Wang, J., & Ye, K. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180539 · Cited by 36

Relevance of host tau in tau seeding and spreading in tauopathies

Ferrer, I., Zelaya, M. V., Aguiló, M., Carmona, M., López‐González, I., Andrés‐Benito, P., Lidón, L., Gavı́n, R., Garcia‐Esparcia, P., & del Rı́o, J. A. (2019) · Brain Pathology · doi:10.1111/bpa.12778 · Cited by 37

Photodynamic sensitizers modulate cytoskeleton structural dynamics in neuronal cells

Dubey, T., & Chinnathambi, S. (2021) · Cytoskeleton · doi:10.1002/cm.21655 · Cited by 36

Expression and Silencing of the Microtubule-Associated Protein Tau in Breast Cancer Cells

Spicakova, T., O'Brien, M. M., Durán, G. E., Sweet-Cordero, A., & Sikic, B. I. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0780 · Cited by 36

Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease

Carroll, T., Guha, S. K., Nehrke, K. W., & Johnson, G. V. W. (2021) · Biology · doi:10.3390/biology10101047 · Cited by 39

GSK-3β phosphorylation of functionally distinct tau isoforms has differential, but mild effects

Voss, K., & Gamblin, T. C. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-18 · Cited by 33

Modulation of RNA Splicing by Oligonucleotides: Mechanisms of Action and Therapeutic Implications

Sergeeva, O. V., Shcherbinina, E. Y., Shomron, N., & Zatsepin, T. S. (2022) · Nucleic Acid Therapeutics · doi:10.1089/nat.2021.0067 · Cited by 34

Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3ζ protein

Sadik, G., Tanaka, T., Kato, K., Yanagi, K., Kudo, T., & Takeda, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.107 · Cited by 33

Truncation of tau at E391 Promotes Early Pathologic Changes in Transgenic Mice

McMillan, P. J., Kraemer, B. C., Robinson, L., Leverenz, J. B., Raskind, M. A., & Schellenberg, G. D. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31823557fb · Cited by 36

Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington’s Disease

Fernández‐Nogales, M., & Lucas, J. J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00574 · Cited by 32

Emerging pathways in genetic Parkinson’s disease: tangles, Lewy bodies and LRRK2

Devine, M. J., & Lewis, P. A. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06707.x · Cited by 30

Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease

Guan, X., Iyaswamy, A., Sreenivasmurthy, S. G., Su, C.-F., Zhu, Z., Liu, J., Kan, Y., Cheung, K., Lu, J., Tan, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073609 · Cited by 32

Electrostatics of Tau Protein by Molecular Dynamics

Castro, T. G., Munteanu, F., & Cavaco-Paulo, A. M. (2019) · Biomolecules · doi:10.3390/biom9030116 · Cited by 32

Saitohin, Which Is Nested in the tau Locus and Confers Allele-specific Susceptibility to Several Neurodegenerative Diseases, Interacts with Peroxiredoxin 6

Gao, L., Tse, S., Conrad, C., & Andreadis, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506116200 · Cited by 31

Microtubule-associated protein tau in murine kidney: role in podocyte architecture

Vallés‐Saiz, L., Peinado-Cahuchola, R., Ávila, J., & Hernández, F. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04106-z · Cited by 32

RNA–Small-Molecule Interaction: Challenging the “Undruggable” Tag

Kaur, J., Sharma, A., Mundlia, P., Sood, V., Pandey, A., Singh, G., & Barnwal, R. P. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01354 · Cited by 33

Depletion of Hemoglobin Transcripts and Long-Read Sequencing Improves the Transcriptome Annotation of the Polar Bear (Ursus maritimus)

Byrne, A., Supple, M. A., Volden, R., Laidre, K. L., Shapiro, B., & Vollmers, C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00643 · Cited by 34

C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1

Sumanasekera, C., Kelemen, O., Beullens, M., Aubol, B. E., Adams, J. A., Sunkara, M., Morris, A., Bollen, M., Andreadis, A., & Stamm, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1289 · Cited by 30

Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation

Fonzo, A. D., Ronchi, D., Gallia, F., Cribiù, F. M., Trezzi, I., Vetro, A., Mina, E. D., Limongelli, I., Bellazzi, R., Ricca, I., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000476 · Cited by 29

Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway

Chen, K.-L., Yuan, R.-Y., Hu, C., & Hsu, C. Y. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.013 · Cited by 31

Novel Tubulin and Tau Neuroprotective Fragments Sharing Structural Similarities with the Drug Candidate NAP (Davuentide)

Gozes, I., Iram, T., Maryanovsky, E., Arviv, C., Rozenberg, L., Schirer, Y., Giladi, E., & Furman-Assaf, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131664 · Cited by 27

Cellular Biology of Tau Diversity and Pathogenic Conformers

Kang, S., Eskandari‐Sedighi, G., Hromádková, L., Safar, J., & Westaway, D. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590199 · Cited by 29

Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers

Mirzaie, A., Nasrollahpour, H., Khalilzadeh, B., Jamali, A. A., Spiteri, R. J., Yousefi, H., Işıldak, İ., & Rahbarghazi‬, R. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117174 · Cited by 28

Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry

Ellis, M. J., Lekka, C., Holden, K. L., Tulmin, H., Seedat, F., O'Brien, D. P., Dhayal, S., Zeissler, M., Knudsen, J. G., Kessler, B. M., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02729-7 · Cited by 26

From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins

Marrero-Winkens, C., Sankaran, C., & Schätzl, H. M. (2020) · Biomolecules · doi:10.3390/biom10091305 · Cited by 26

Dityrosine cross-linking and its potential roles in Alzheimer’s disease

Maina, M. B., Al‐Hilaly, Y. K., & Serpell, L. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1132670 · Cited by 27

Finding Order within Disorder: Elucidating the Structure of Proteins Associated with Neurodegenerative Disease

Huang, A., & Stultz, C. M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.40 · Cited by 26

Age-dependent changes in neuronal distribution of CacyBP/SIP: comparison to tubulin and the tau protein

Filipek, A., Schneider, G., Mietelska‐Porowska, A., Figiel, I., & Niewiadomska, G. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0062-3 · Cited by 25

Quantitative prediction of variant effects on alternative splicing in MAPT using endogenous pre-messenger RNA structure probing

Kumar, J., Lackey, L., Waldern, J. M., Dey, A., Mustoe, A. M., Weeks, K. M., Mathews, D. H., & Laederach, A. (2022) · eLife · doi:10.7554/elife.73888 · Cited by 24

Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes

Jung, H. J., Park, S. S., Mok, J. O., Lee, T. K., Park, C. S., & Park, S. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.01.012 · Cited by 25

Nanotechnology for tau pathology in Alzheimer's disease

Ma, R., Mu, Q., Xi, Y., Liu, G., & Liu, C. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101145 · Cited by 23

Abolishing Tau cleavage by caspases at Aspartate421 causes memory/synaptic plasticity deficits and pre-pathological Tau alterations

Biundo, F., d’Abramo, C., Tambini, M. D., Zhang, H., Prete, D. D., Vitale, F., Giliberto, L., Arancio, O., & D'adamio, L. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.165 · Cited by 25

hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3′ Splice Sites

Liu, Y., Kim, D., Choi, N., Oh, J., Ha, J., Zhou, J., Zheng, X., & Shen, H. (2020) · Cells · doi:10.3390/cells9040936 · Cited by 23

Heparan Sulfate Proteoglycans in Tauopathy

Zhu, Y., Gandy, L. A., Zhang, F., Liu, J., Wang, C., Blair, L. J., Linhardt, R. J., & Wang, L. (2022) · Biomolecules · doi:10.3390/biom12121792 · Cited by 27

DNAzyme-driven tripedal DNA walker triggered hybridization chain reaction for label-free electrochemical detection of Alzheimer’s tau protein

Wei, J., Qiu, Z., Yu, D., Yin, Y., Tang, Q., Liao, X., Zhang, G., Liu, Z., & Gao, F. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.133656 · Cited by 24

Brain Damage - Bridging Between Basic Research and Clinics

González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 21

Therapeutic implications of glycogen synthase kinase-3β in Alzheimer’s disease: a novel therapeutic target

Mandlik, D. S., Mandlik, S. K., & Arulmozhi, S. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2130297 · Cited by 22

Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective

Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25

Correlation between Cognitive Impairment and Peripheral Biomarkers - Significance of Phosphorylated Tau and Amyloid-β in Alzheimer’s Disease: A New Insight

Sarkar, S., Bhui, U., Kumar, B., Ashique, S., Kumar, P., Sharma, H., Bhowmick, M., Pal, R., & Kumar, T. (2024) · Current Psychiatry Research and Reviews · doi:10.2174/0126660822329981241007105405 · Cited by 25

Alternative Splicing and Hypoxia Puzzle in Alzheimer’s and Parkinson’s Diseases

Jakubauskienė, E., & Kanopka, A. (2021) · Genes · doi:10.3390/genes12081272 · Cited by 21

Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington’s Disease Brain

Petry, S., Nateghi, B., Keraudren, R., Sergeant, N., Planel, E., Hébert, S. S., & St‐Amour, I. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.014 · Cited by 20

Evolutionary perspective of Big tau structure: 4a exon variants of MAPT

Fischer, I. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1019999 · Cited by 20

The RNA encoding the microtubule-associated protein tau has extensive structure that affects its biology

Chen, J. L., Moss, W. N., Spencer, A., Zhang, P., Childs‐Disney, J. L., & Disney, M. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219210 · Cited by 18

Cytoskeletal Transport in the Aging Brain: Focus on the Cholinergic System

Niewiadomska, G., Baksalerska-Pazera, M., & Riedel, G. (2006) · Reviews in the Neurosciences · doi:10.1515/revneuro.2006.17.6.581 · Cited by 20

Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging

Gumucio, A., Lannfelt, L., & Nilsson, L. N. G. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-148 · Cited by 19

Phosphorylated nucleolar Tau protein is related to the neuronal in vitro differentiation

Federico, C., Gil, L., Bruno, F., D’Amico, A. G., D’Agata, V., & Saccone, S. (2018) · Gene · doi:10.1016/j.gene.2018.04.051 · Cited by 19

Identification of HnRNPC as a novel Tau exon 10 splicing factor using RNA antisense purification mass spectrometry

Xing, S., Wang, J., Wu, R., Hefti, M. M., Crary, J. F., & Lu, Y. (2021) · RNA Biology · doi:10.1080/15476286.2021.2015175 · Cited by 18

Characterization of the Tau Interactome in Human Brain Reveals Isoform-Dependent Interaction with 14-3-3 Family Proteins

Betters, R. K., Luhmann, E. K., Gottschalk, A. C., Xu, Z., Shin, M. R., Ptak, C. P., Fiock, K. L., Radoshevich, L., & Hefti, M. M. (2023) · eNeuro · doi:10.1523/eneuro.0503-22.2023 · Cited by 16

A familial Danish dementia rat shows impaired presynaptic and postsynaptic glutamatergic transmission

Yin, T., Yao, W., Norris, K. A., & D’Adamio, L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101089 · Cited by 14

Novel PSEN1 mutations (H214N and R220P) associated with familial Alzheimer's disease identified by targeted exome sequencing

Piccoli, E., Rossi, G., Rossi, T., Pelliccioni, G., D’Amato, I., Tagliavini, F., & Fede, G. D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.134 · Cited by 15

Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole genome gene expression and splicing analysis

Smith, R. C. (2016) · Cited by 15

Posttranscriptional regulation of neurofilament proteins and tau in health and disease

Yuan, A., & Nixon, R. A. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.017 · Cited by 16

Pathology of Neurodegenerative Diseases

Kim, Y. S., Kim, Y.-K., Hwang, O., & Dong, J. (2012) · InTech eBooks · doi:10.5772/38028 · Cited by 16

Tau 6D and 6P Isoforms Inhibit Polymerization of Full-Length Tau in Vitro

LaPointe, N. E., Horowitz, P. M., Guillozet-Bongaarts, A. L., Silva, A., Andreadis, A., & Binder, L. I. (2009) · Biochemistry · doi:10.1021/bi901304u · Cited by 20

Tau exon 6 is regulated by an intricate interplay of trans factors and cis elements, including multiple branch points

Wang, J., Tse, S., & Andreadis, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04252.x · Cited by 17

Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy?

Fernández-Gómez, F.-J., Tran, H., Dhaenens, C., Caillet‐Boudin, M., Schraen‐Maschke, S., Blum, D. L., Sablonnière, B., Buée‐Scherrer, V., Buée, L., & Sergeant, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_17 · Cited by 15

Zebrafish Models to Study New Pathways in Tauopathies

Barbereau, C., Cubedo, N., Maurice, T., & Rossel, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094626 · Cited by 14

Capacity for Seeding and Spreading of Argyrophilic Grain Disease in a Wild-Type Murine Model; Comparisons With Primary Age-Related Tauopathy

Ferrer, I., Andrés‐Benito, P., Sala‐Jarque, J., Gil, V., & del Rı́o, J. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00101 · Cited by 14

Functional characterization of the human-specific (type II) form of kallikrein 8, a gene involved in learning and memory

Lu, Z., Huang, Q. M., & Su, B. (2009) · Cell Research · doi:10.1038/cr.2009.4 · Cited by 14

Kinesin Expression in the Central Nervous System of Humans and Transgenic hSOD1G93A Mice with Amyotrophic Lateral Sclerosis

Kuźma‐Kozakiewicz, M., Chudy, A., Gajewska, B., Dziewulska, D., Usarek, E., & Barańczyk‐Kuźma, A. (2012) · Neurodegenerative Diseases · doi:10.1159/000339529 · Cited by 13

Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration

Ding, Y., Lei, L., Lai, C., & Tang, Z. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180917 · Cited by 13

Lineage-specific splicing regulation of MAPT gene in the primate brain

Recinos, Y., Bao, S., Wang, X., Phillips, B. L., Yeh, Y.-T., Weyn‐Vanhentenryck, S. M., Swanson, M. S., & Zhang, C. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100563 · Cited by 12

Excessive Alcohol Use as a Risk Factor for Alzheimer’s Disease: Epidemiological and Preclinical Evidence

Anton, P. E., Maphis, N. M., Linsenbardt, D. N., & Coleman, L. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-81908-7_10 · Cited by 12

Differential Effects of Human Tau Isoforms to Neuronal Dysfunction and Toxicity in the Drosophila CNS

Vourkou, E., Paspaliaris, V., Bourouliti, A., Zerva, M.-C., Prifti, E., Papanikolopoulou, K., & Skoulakis, E. M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112985 · Cited by 12

Using FRET-Based Biosensor Cells to Study the Seeding Activity of Tau and α-Synuclein

Maina, K. N., Smet‐Nocca, C., & Bitan, G. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2597-2_10 · Cited by 13

Misregulation of Tau Alternative Splicing in Neurodegeneration and Dementia

Andreadis, A. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_5 · Cited by 72

Tau splicing and the intricacies of dementia

Andreadis, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22842 · Cited by 88

S3–03–04: Modulation of tau dys/function by regulated alternative splicing

Andreadis, A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.177

Tau Isoforms: Gaining Insight into MAPT Alternative Splicing

Corsi, A., Bombieri, C., Valenti, M. T., & Romanelli, M. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315383 · Cited by 118

Tau mis-splicing in the pathogenesis of neurodegenerative disorders

Park, S. A., Ahn, S. I., & Gallo, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.8.084 · Cited by 100